Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

T-cell gene therapy developed at Cell Genesys markedly reduces TAG-72 blood levels

May 20, 1998

Preliminary clinical results indicate good tolerability for LGD-1550 in cancer patients

May 20, 1998

Promising phase I/II findings in NSCLC reported for INGN-201 at ASCO

May 20, 1998

Pharmacokinetics of capecitabine affected by food

May 20, 1998

C225 + radiotherapy produces 100% response rate in head and neck cancer

May 19, 1998

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

May 19, 1998

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

May 19, 1998

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

May 19, 1998

Mechanism of antitumor activity of clotrimazole identified

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...